Expression of VEGF-C/VEGFR-3 in Human Laryngeal Squamous Cell Carcinomas and its Significance for Lymphatic Metastasis |
Wang, Zhongliang
(Department of Otolaryngology-Head and Neck Surgery, Subei People's Hospital of Jiangsu Province)
Chen, Yao (Department of Human Anatomy, West China of Preclinical and Forensic Medicine, Sichuan University) Li, Xiaofeng (Department of Otolaryngology-Head and Neck Surgery, Subei People's Hospital of Jiangsu Province) Xu, Li (Department of Otolaryngology-Head and Neck Surgery, Subei People's Hospital of Jiangsu Province) Ma, Wei (Department of Otolaryngology-Head and Neck Surgery, Subei People's Hospital of Jiangsu Province) Chang, Lingmei (Department of Otolaryngology-Head and Neck Surgery, Subei People's Hospital of Jiangsu Province) Ju, Funian (Department of Otolaryngology-Head and Neck Surgery, Subei People's Hospital of Jiangsu Province) |
1 | Veikkola T, Alitalo K (1999). VEGFs receptors and angiogenesis. Scmin Cancer Biol, 9, 211. DOI |
2 | Yamamoto E, Kohama G, Sunakawa H, et al (1983). Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer, 51, 2175-80. DOI |
3 | Yang Y, Ge RM (2002). Expression of VEGF and VEGF-C in laryngeal carcinoma and their clinical significance. J Clin Otorhinolaryngol, 16, 650. |
4 | Yonemura Y, Fushida S, Bando E, et al (2001). Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer, 37, 918. DOI |
5 | Zhongliang W, Yao C, Rueixiang L (2002). Advanced in the researches for vascular endothelial growth factor (VEGF)-C and vascular endothelial growth factor receptor (VEGFR)-3. China J Cancer Prev Treat, 9, 454. |
6 | Kaipainen A, Korhonen J, Mustonen T, et al (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA, 92, 3566-70. DOI |
7 | Kowalski LP, Medina JE (1998). Nodal metastases: predictive factors. Otolaryngol Clin North Am, 31, 621-37. DOI |
8 | Kukk E, Lymboussaki A, Taira S, et al (1996). VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development, 122, 3829-37. |
9 | Mork J (1998). Forty years of monitoring head and neck cancer in Norway--no good news. Anticancer Res, 18, 3705-8. |
10 | Ogawa S, Oku A, Sawano A, et al (1998). A novel type of vascular endothelial factor, VEGF-E (NA-7 VEGF), preferentially utilizes KDR/Flt-1 receptor and carries apotent mitotic activity without beparin-binding domain. J Biol Chem, 273, 31273. DOI |
11 | Oh SJ, Jeltsch MM, Birkenhager R, et al (1997). VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol, 188, 96-109. DOI |
12 | Pajusola K, Aprelikova O, Korhonen J, et al (1992). FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res, 52, 5738-43. |
13 | Salven P, Lymboussaki A, Heikkila P, et al (1998). Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human cancers. Am J Pathol, 153, 103- 8. DOI |
14 | Shushanov S, Bronstein M, Adelaide J (2000). VEGFc and VEGFR3 expression in human thyroid pathologies. Int j cancer, 86, 47. DOI |
15 | Sobin LH, Wittekind Ch (1997). UICC TNM classification of malignant cancers, 5thed. New York John Wiley. |
16 | Joukov V, Pajusola K, Kaipainen A, et al (1996). A new vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo J, 15, 290. |
17 | Tsurusaki T, Kanda S, Sakai H, et al (1999). Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer, 80, 309. DOI |
18 | Eriksson U, Alitalo K (1999). Structure expression and receptorbinding properties of novel vascular endothelial growth factors. In: Claesson-Welsb L, editor. Vascular Growth Factors and Angiogenesis. Berlin Springer-Verlag |
19 | Fellmer PT, Sato K, Tanaka R, et al (1999). Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. Surgery, 126, 1056. DOI |
20 | Jeltsch M, Kaipainen A, Joukov V, et al (1997). Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science, 276, 1423-5. DOI |